ArticleJournal for immunotherapy of cancer2022

Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer.

Myrto K Moutafi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.